EMPAGEN TRIO 25/5/1000MG TAB

Empagen Trio combines three active ingredients—empagliflozin, linagliptin, and metformin—in a single tablet formulation designed for comprehensive glycemic management. This triple-action combination addresses multiple pathways in glucose regulation, making it suitable for patients requiring intensified diabetes control. The 25/5/1000mg dosage delivers potent therapeutic efficacy while maintaining convenient once-daily dosing. Ideal for type 2 diabetes management when monotherapy or dual therapy proves insufficient.